These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21397156)

  • 21. Autoimmune blisters in the gingiva.
    Sasaki R; Okamoto T
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32895248
    [No Abstract]   [Full Text] [Related]  

  • 22. Mucous membrane pemphigoid: management of advanced ocular disease with intravenous cyclophosphamide and amniotic membrane transplantation.
    Yesudian PD; Armstrong S; Cawood JI; Allan RB; Mendelsohn SS; Kaye SB
    Br J Dermatol; 2005 Sep; 153(3):692-4. PubMed ID: 16120180
    [No Abstract]   [Full Text] [Related]  

  • 23. Mucosal substrates successfully identify the autoantigen in a case of mucous membrane pemphigoid.
    Kamaguchi M; Iwata H; Ujiie H; Ohga N; Kitagawa Y; Shimizu H
    J Dtsch Dermatol Ges; 2018 Aug; 16(8):1032-1034. PubMed ID: 30117705
    [No Abstract]   [Full Text] [Related]  

  • 24. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
    J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
    Taverna JA; Lerner A; Bhawan J; Demierre MF
    J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral mucosal diseases: mucous membrane pemphigoid.
    Scully C; Lo Muzio L
    Br J Oral Maxillofac Surg; 2008 Jul; 46(5):358-66. PubMed ID: 17804127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII.
    Stump M; Messingham KN; Fairley JA
    Br J Dermatol; 2019 Oct; 181(4):835-836. PubMed ID: 30916378
    [No Abstract]   [Full Text] [Related]  

  • 28. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucous membrane pemphigoid presenting with isolated esophageal involvement: a case report.
    Sallout H; Anhalt GJ; Al-Kawas FH
    Gastrointest Endosc; 2000 Sep; 52(3):429-33. PubMed ID: 10968869
    [No Abstract]   [Full Text] [Related]  

  • 30. Cicatricial pemphigoid (benign mucous membrane pemphigoid).
    Terezhalmy GT; Bergfeld WF
    Quintessence Int; 1998 Jul; 29(7):429-37. PubMed ID: 9759059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y; Amin KG; Mohan K; Ahmed AR
    Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
    Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
    Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

  • 34. Mucous Membrane Pemphigoid Presenting With Esophageal Manifestations: A Case Series.
    DeGrazia T; Eisenstadt R; Willingham FF; Feldman R
    Am J Gastroenterol; 2019 Oct; 114(10):1695-1697. PubMed ID: 31498153
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-p200/anti-laminin γ1 pemphigoid and BP180 NC16A/4575- positive mucous membrane pemphigoid : late diagnosis in a patient with disease-related loss of vision and multiple previous surgical interventions].
    Kaune KM; Kasperkiewicz M; Tams D; Bergmann M; Zutt M
    Hautarzt; 2015 Jan; 66(1):60-4. PubMed ID: 25339385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
    Prey S; Robert PY; Drouet M; Sparsa A; Roux C; Bonnetblanc JM; Bédane C
    Acta Derm Venereol; 2007; 87(1):74-5. PubMed ID: 17225020
    [No Abstract]   [Full Text] [Related]  

  • 38. A rare unilateral case of ocular mucous membrane pemphigoid.
    Roufas A; Kim P; Reeves D; Sutton G
    Cornea; 2010 Dec; 29(12):1462-4. PubMed ID: 20847684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
    Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
    Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulins and mucous membrane pemphigoid.
    Mignogna MD; Leuci S; Piscopo R; Bonovolontà G
    Ophthalmology; 2008 Apr; 115(4):752-752.e1. PubMed ID: 18387410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.